Key facts
- Science (Therapeutic Devices)’s last known valuation is $1.5B (Feb 2026).
- It has raised $519.6M; the latest was Later Stage VC ($230.0M) in Feb 2026.
- Notable investors include Y Combinator, Khosla Ventures, Lightspeed Venture Partners, In-Q-Tel, Quiet Capital — 32 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 32 names
- ·Watchlist + deal alerts for Science (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Science (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Science (Therapeutic Devices)
Developer of a brain-computer interface (BCI) technology designed to understand and engineer the brain. The company's technology aims to restore quality of life to those with debilitating conditions for which there are no treatment options and provides state-of-the-art components and vertically integrated infrastructure, creating devices aimed at restoring vision, cognition and mobility to support progress across neural engineering industry, enabling doctors to treat serious brain diseases in the short term without drilling holes into patients' heads.
- Sector
- Healthcare
- HQ
- Alameda, CA, United States
- Founded
- 2021
- Employees
- 150
- Website
- science.xyz/
- Ownership
- Privately Held (backing)
Science (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Science (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Science (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.